LI-RADS 治疗反应算法:性能与诊断准确性
本回顾性研究纳入2006至2016年间接受单纯动脉栓塞治疗肝细胞癌并后续行肝移植的45例成人(共63个病灶),由3名放射科医师独立应用CT/MRI LI-RADS 2017治疗反应算法评估,并与移植后组织病理学对照。结果显示LR-TR Viable预测不完全坏死的准确率为60%-65%、阳性预测值为86%-96%;LR-TR Nonviable预测完全坏死的准确率为67%-71%、阴性预测值为81%-87%;读者间一致性为中等(κ=0.55)。
要点
- LR-TR Viable预测不完全病理坏死的准确率60%-65%、阳性预测值86%-96%。
- LR-TR Nonviable预测完全病理坏死的准确率67%-71%、阴性预测值81%-87%。
- 27%(17/63)病灶被共识判为LR-TR Equivocal,其中12个为不完全坏死。
核心结论
- LI-RADS 2017治疗反应算法在病灶被判为Viable或Nonviable时,对单纯动脉栓塞治疗肝细胞癌的组织病理学活性具有高预测价值和中等读者间一致性。
研究设计与样本
- 回顾性研究,纳入2006至2016年间接受单纯动脉栓塞治疗肝细胞癌并后续行肝移植的45例成人(平均年龄57.1岁±8.2,13名女性),共63个病灶;3名放射科医师独立应用CT/MRI LI-RADS 2017治疗反应算法评估,以移植后组织病理学为参考标准。
诊断标准与关键数值
- 以移植病理完全(100%)或不完全(<100%)坏死为参考:LR-TR Viable预测不完全坏死的准确率60%-65%、阳性预测值86%-96%;LR-TR Nonviable预测完全坏死的准确率67%-71%、阴性预测值81%-87%;读者间一致性κ=0.55(95%CI:0.47,0.67)。
临床应用与阅片要点
- 阅片时按LI-RADS 2017治疗反应算法将病灶判为Viable或Nonviable时,对病理活性的预测价值较高,但需注意LR-TR Equivocal并不少见(共识下27%,17/63),其中多数为不完全坏死(12/17)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background In 2017, the Liver Imaging Reporting and Data System (LI-RADS) included an algorithm for the assessment of hepatocellular carcinoma (HCC) treated with local-regional therapy. The aim of the algorithm was to enable standardized evaluation of treatment response to guide subsequent therapy. However, the performance of the algorithm has not yet been validated in the literature. Purpose To evaluate the performance of the LI-RADS 2017 Treatment Response algorithm for assessing the histopathologic viability of HCC treated with bland arterial embolization. Materials and Methods This retrospective study included patients who underwent bland arterial embolization for HCC between 2006 and 2016 and subsequent liver transplantation. Three radiologists independently assessed all treated lesions by using the CT/MRI LI-RADS 2017 Treatment Response algorithm. Radiology and posttransplant histopathology reports were then compared. Lesions were categorized on the basis of explant pathologic findings as either completely (100%) or incompletely (<100%) necrotic, and performance characteristics and predictive values for the LI-RADS Treatment Response (LR-TR) Viable and Nonviable categories were calculated for each reader. Interreader association was calculated by using the Fleiss κ. Results A total of 45 adults (mean age, 57.1 years ± 8.2; 13 women) with 63 total lesions were included. For predicting incomplete histopathologic tumor necrosis, the accuracy of the LR-TR Viable category for the three readers was 60%-65%, and the positive predictive value was 86%-96%. For predicting complete histopathologic tumor necrosis, the accuracy of the LR-TR Nonviable category was 67%-71%, and the negative predictive value was 81%-87%. By consensus, 17 (27%) of 63 lesions were categorized as LR-TR Equivocal, and 12 of these lesions were incompletely necrotic. Interreader association for the LR-TR category was moderate (κ = 0.55; 95% confidence interval: 0.47, 0.67). Conclusion The Liver Imaging Reporting and Data System 2017 Treatment Response algorithm had high predictive value and moderate interreader association for the histopathologic viability of hepatocellular carcinoma treated with bland arterial embolization when lesions were assessed as Viable or Nonviable. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Gervais in this issue.
引用
- Shropshire EL, Chaudhry M, Miller CM, et al. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology. 2019. PMID: 31038409. doi:10.1148/radiol.2019182135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。